Literature DB >> 21705477

The recurrent cervical swelling syndrome.

C Franceschi1, S Gianesini, A Bahnini, C Laurian, E Menegatti, P Zamboni.   

Abstract

The objective of this study is to report an overlooked cause of cervical swelling linked to a thoracic duct (TD) intraluminal obstruction. Four consecutive patients underwent supraclavicular fossa echo-colour-Doppler assessment (ECD) because of recurrent spontaneous cervical swelling. In all patients, during the swelling period we documented a TD dilation with hyperechogenic content, resulting undetectable during asymptomatic periods; ECD also allowed an effective differential diagnosis with TD cysts, obstructive malignancy or other causes of cervical swelling. In conclusion, ECD is to be considered an effective tool in cervical swelling and TD anomalies investigation.

Entities:  

Mesh:

Year:  2011        PMID: 21705477     DOI: 10.1258/phleb.2011.011006

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  3 in total

1.  Spontaneous cervical swelling syndrome as a rare cause of neck edema: case series and literature review.

Authors:  Albrecht Betrains; Robert Hermans; Olivier Gheysens; Vincent Vander Poorten; Willy E Peetermans; Steven Vanderschueren
Journal:  Oxf Med Case Reports       Date:  2021-05-24

2.  MR-lymphangiography identifies lymphatic pathologies in patients with idiopathic recurrent cervical swelling.

Authors:  Marius Vach; Julia Wagenpfeil; Andreas Henkel; Sebastian Strieth; Julian Alexander Luetkens; Yon-Dschun Ko; Hans Heinz Schild; Ulrike Irmgard Attenberger; Claus Christian Pieper
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-19

Review 3.  Recurrent thoracic duct cyst of the left supraclavicular fossa: A retrospective study of 6 observational case series and literature review.

Authors:  Julie Planchette; Clara Jaccard; Audrey Nigron; Jean-Baptiste Chadeyras; Guillaume Le Guenno; Benjamin Castagne; Yvan Jamilloux; Anne-Sophie Resseguier; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.